Human Tissue Act 1983 Regulation relating to prescribed contaminants (1995-158) [GG No 47 of 21.4.1995] (NSW)

1995—No. 158

HUMAN TISSUE ACT 1983—REGULATION

(Relating to prescribed contaminants)

NEW SOUTH WALES

[Published in Gazette No. 47 of 21 April 1995]

HIS Excellency the Governor, with the advice of the Executive Council, and in pursuance of the Human Tissue Act 1983, has been pleased to make the Regulation set forth hereunder.

ANDREW REFSHAUGE

Deputy Premier and Minister for Health.

Commencement

1. This Regulation commences on 21 April 1995.

Amendments

2. The Human Tissue Regulation 1984 is amended:

(a) matter:

by inserting in clause 11, in alphabetical order, the following Human T-lymphotropic virus Type-I (HTLV-I) antibody.

(b)

by inserting in clause 4 (2) of Schedule 2, in alphabetical order, Human T-lymphotropic virus Type-I (HTLV-I) antibody.

(c)

by inserting in clause 3 (3) of Schedule 3, in alphabetical order, Human T-lymphotropic virus Type-I (HTLV-I) antibody.

1995—No. 158

EXPLANATORY NOTE

The object of this Regulation is to amend the Human Tissue Regulation 1984 to declare the human T-lymphotropic virus Type-I (HTLV-I) and the human T-lymphotropic virus Type-I (HTLV-I) antibody to be prescribed contaminants for the purposes of the Human Tissue Act 1983. The Act restricts the taking of legal proceedings in respect of the transmission of a prescribed contaminant as a result of a blood transfusion or other treatment involving blood or a blood product or artificial insemination.

The Regulation also adds the human T-lymphotropic virus Type-I (HTLV-I) antibody to the list of prescribed contaminants for which a donor’s blood must be tested when donating blood or semen.

This Regulation is made under the power conferred by the definition of “prescribed contaminant” in section 4 (1) of the Human Tissue Act 1983 and under section 21I of the Act.